Bentley; Jonathan Mark
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bentley; Jonathan Mark.The latest application filed is for "fused imidazole and pyrazole derivatives as modulators of tnf activity".
- Bentley; Jonathan Mark - Abingdon GB
- Bentley; Jonathan Mark - Oxon GB
- Bentley; Jonathan Mark - Winnersh GB
- Bentley; Jonathan Mark - Wokingham GB
- Bentley; Jonathan Mark - Reading GB
- Bentley; Jonathan Mark - Berkshire GB
| Patent | Date |
|---|---|
| Fused imidazole and pyrazole derivatives as modulators of TNF activity Grant 9,868,749 - Alexander , et al. January 16, 2 | 2018-01-16 |
| Substituted imidazo[1,2-a]pyrazines as TNF activity modulators Grant 9,475,820 - Bentley , et al. October 25, 2 | 2016-10-25 |
| Fused Imidazole and Pyrazole Derivatives As Modulators of TNF Activity App 20160297837 - Alexander; Rikki Peter ; et al. | 2016-10-13 |
| Imidazopyridine derivatives as modulators of TNF activity Grant 9,309,243 - Bentley , et al. April 12, 2 | 2016-04-12 |
| Imidazopyridine Derivatives as Modulators of TNF Activity App 20150203486 - Bentley; Jonathan Mark ; et al. | 2015-07-23 |
| Imidazopyrazine Derivatives as Modulators of TNF Activity App 20150191482 - Bentley; Jonathan Mark ; et al. | 2015-07-09 |
| Triazine-oxadiazoles Grant 8,895,733 - Barker , et al. November 25, 2 | 2014-11-25 |
| Azetidinecarboxamide Derivatives And Their Use In The Treatment Of CB1 Receptor Mediated Disorders App 20090181939 - Davidson; James Edward Paul ; et al. | 2009-07-16 |
| Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity Grant 7,323,466 - Bentley , et al. January 29, 2 | 2008-01-29 |
| Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles Grant 7,253,281 - Bentley , et al. August 7, 2 | 2007-08-07 |
| Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs App 20070173486 - Davidson; James Edward Paul ; et al. | 2007-07-26 |
| Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino [1,2-a] indoles App 20070106076 - Bentley; Jonathan Mark ; et al. | 2007-05-10 |
| 1,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivatives Grant 7,098,337 - Adams , et al. August 29, 2 | 2006-08-29 |
| New morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity App 20060178510 - Bentley; Jonathan Mark ; et al. | 2006-08-10 |
| Piperazine derivatives Grant 7,022,707 - Adams , et al. April 4, 2 | 2006-04-04 |
| Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a] indoles App 20050239789 - Bentley, Jonathan Mark ; et al. | 2005-10-27 |
| Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles Grant 6,933,387 - Bentley , et al. August 23, 2 | 2005-08-23 |
| Novel piperazine derivatives App 20040235859 - Adams, David Reginald ; et al. | 2004-11-25 |
| Indole derivatives process for their preparation, pharmaceutical compositions containing them and their medicinal application Grant 6,706,750 - Bentley , et al. March 16, 2 | 2004-03-16 |
| Anti-obesity 1, 2, 3, 4, 10, 10a-hexahydropyrazino[1, 2-a] indoles App 20030216401 - Bentley, Jonathan Mark ; et al. | 2003-11-20 |
| Piperazine derivatives App 20030207888 - Adams, David Reginald ; et al. | 2003-11-06 |
| Fused indole derivatives Grant 6,610,685 - Bentley , et al. August 26, 2 | 2003-08-26 |
| Indoline Derivatives And Method Of Treating Obesity App 20020183349 - Bentley, Jonathan Mark ; et al. | 2002-12-05 |
| Indoline derivatives and method of treating obesity Grant 6,479,534 - Bentley , et al. November 12, 2 | 2002-11-12 |
| Novel indole derivatives App 20020160997 - Bentley, Jonathan Mark ; et al. | 2002-10-31 |
| Novel piperazine derivatives App 20020143020 - Adams, David Reginald ; et al. | 2002-10-03 |
| Aza- indolyl derivatives for treating obesity App 20010025039 - Bentley, Jonathan Mark ; et al. | 2001-09-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 